Use access key #2 to skip to page content.
$16.04 0.23 (1.45%)
7/8/2008 4:00 PM

Omrix Biopharmaceuticals, Inc. (OMRI)

CAPS Rating:
****

A commercial-stage biopharmaceutical company that develops and markets innovative biological products.

View All Commentary (OMRI)

Recs

0

Avatar ResearchLover (93.53) Submitted: 5/15/08 2:36 PM : Outperform Start Price: $15.33 OMRI Score: 14.88

Looks like analysts give it a price target in the 20s, and growth projections are up, though fluctuating. Profit margin looks good. I actually have owned competitor KG since december 2007, but that is a defensive position, whereas this is one with somewhat risky growth prospects.

Report this Post Replies: 0 | Reply

Featured Broker Partners